179 related articles for article (PubMed ID: 307057)
1. Biochemical and behavioral alterations in developing rats treated with 5,7-dihydroxytryptamine.
Breese GR; Vogel RA; Mueller RA
J Pharmacol Exp Ther; 1978 Jun; 205(3):587-95. PubMed ID: 307057
[TBL] [Abstract][Full Text] [Related]
2. Behavioral and prolactin responses to 5-hydroxytryptophan in rats treated during development with 5,7-dihydroxytryptamine.
Breese GR; Vogel RA; Kuhn CM; Mailman RB; Mueller RA; Schanberg SM
Brain Res; 1978 Oct; 155(2):263-75. PubMed ID: 308387
[TBL] [Abstract][Full Text] [Related]
3. Behavioral and biochemical interactions of 5,7-dihydroxytryptamine with various drugs when administered intracisternally to adult and developing rats.
Breese GR; Cooper BR
Brain Res; 1975 Nov; 98(3):517-27. PubMed ID: 1242372
[TBL] [Abstract][Full Text] [Related]
4. Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats.
Nabeshima T; Yamaguchi K; Ishikawa K; Furukawa H; Kameyama T
J Pharmacol Exp Ther; 1987 Dec; 243(3):1139-46. PubMed ID: 2826756
[TBL] [Abstract][Full Text] [Related]
5. Neonatal 5-hydroxytryptamine depletion induces depressive-like behavior in adult rats.
Kostowski W; Krzaścik P
Pol J Pharmacol; 2003; 55(6):957-63. PubMed ID: 14730089
[TBL] [Abstract][Full Text] [Related]
6. Intracisternal 5,7-dihydroxytryptamine lesions in neonatal and adult rats: comparison of response to 5-hydroxytryptophan.
Pranzatelli MR; Dollison AM; Hlibczuk V
Dev Neurosci; 1989; 11(3):205-11. PubMed ID: 2788568
[TBL] [Abstract][Full Text] [Related]
7. Intracortical 5,7-dihydroxytryptamine depletes brain serotonin concentrations without affecting spontaneous activity.
Black RS; Robinson RG
Pharmacol Biochem Behav; 1985 Feb; 22(2):327-31. PubMed ID: 3983223
[TBL] [Abstract][Full Text] [Related]
8. Supersensitivity to L-5-hydroxytryptophan after 5,7-dihydroxytryptamine injections in desmethylimipramine- and nomifensine-pretreated rats: behavioral evidence for postsynaptic supersensitivity.
Ortmann R; Martin S; Waldmeier PC
Psychopharmacology (Berl); 1981; 74(2):109-14. PubMed ID: 6115443
[TBL] [Abstract][Full Text] [Related]
9. [Effect of the intracisternal administration of the neurotoxins 6-hydroxydopamine and 5,7-dihydroxytryptamine on the formation of the passive avoidance reaction and the biogenic amine level in the brain of rats].
Shabanov PD; Bul'on VV; Lénárd L
Fiziol Zh SSSR Im I M Sechenova; 1988 Jul; 74(7):920-3. PubMed ID: 3141223
[TBL] [Abstract][Full Text] [Related]
10. Serotonin-lesion myoclonic syndromes. I. Neurochemical profile and S-1 receptor binding.
Pranzatelli MR; Rubin G; Snodgrass SR
Brain Res; 1986 Jan; 364(1):57-66. PubMed ID: 3484992
[TBL] [Abstract][Full Text] [Related]
11. Brainstem serotonergic hyperinnervation modifies behavioral supersensitivity to 5-hydroxytryptophan in the rat.
Pranzatelli MR; Huang YY; Dollison AM; Stanley M
Brain Res Dev Brain Res; 1989 Nov; 50(1):89-99. PubMed ID: 2582610
[TBL] [Abstract][Full Text] [Related]
12. Effect of 5,7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in rats.
Kuhn CM; Vogel RA; Mailman RB; Mueller RA; Schanberg SM; Breese GR
Psychopharmacology (Berl); 1981; 73(2):188-93. PubMed ID: 6785814
[TBL] [Abstract][Full Text] [Related]
13. Serotonin-lesion myoclonic syndromes. II. Analysis of individual syndrome elements, locomotor activity and behavioral correlations.
Pranzatelli MR; Snodgrass SR
Brain Res; 1986 Jan; 364(1):67-76. PubMed ID: 3484993
[TBL] [Abstract][Full Text] [Related]
14. Behavioral evidence for supersensitivity following destruction of central serotonergic nerve terminals by 5,7-dihydroxytryptamine.
Trulson ME; Eubanks EE; Jacobs BL
J Pharmacol Exp Ther; 1976 Jul; 198(1):23-32. PubMed ID: 132525
[TBL] [Abstract][Full Text] [Related]
15. [Effects of intraventricular injection of 5,7-dihydroxytryptamine on monoamines and sleep in the kitten (author's transl)].
Adrien J; Bourgoin S; Laguzzi R; Hamon M
J Physiol (Paris); 1981; 77(2-3):425-30. PubMed ID: 7288656
[TBL] [Abstract][Full Text] [Related]
16. Effects of adult or neonatal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine on locomotor activity, monoamine levels, and response to caffeine.
Erinoff L; Snodgrass SR
Pharmacol Biochem Behav; 1986 Apr; 24(4):1039-45. PubMed ID: 3086901
[TBL] [Abstract][Full Text] [Related]
17. Early postnatal administration of 5,7-DHT: effects on serotonergic neurons and terminals.
Towle AC; Breese GR; Mueller RA; Coyle S; Lauder JM
Brain Res; 1984 Sep; 310(1):67-75. PubMed ID: 6383521
[TBL] [Abstract][Full Text] [Related]
18. A study of the central effects of 5,6-dihydroxytryptamine.
Longo VG; Scotti de Carolis A; Liuzzi A; Massotti M
Adv Biochem Psychopharmacol; 1974; 10():109-20. PubMed ID: 4546514
[No Abstract] [Full Text] [Related]
19. [Compensation in behavioral disorders in rats receiving 5,7-DHT neonatally and by transplantation of embryonic raphe nucleus tissue].
Semenova TP; Gromov EA; Grishchenko NI; Nesterova IV; Bragin AG; Vinogradova OS; Kulikov AV; Smirnova GN; Tret'iak TM
Zh Vyssh Nerv Deiat Im I P Pavlova; 1990; 40(1):156-64. PubMed ID: 2162591
[TBL] [Abstract][Full Text] [Related]
20. [Anxiety-like behavior in rats neonatally and adultly treated with 5,7-dihydroxytryptamine].
Yamada I; Iwasaki T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Oct; 22(5):145-51. PubMed ID: 12451684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
